XML 33 R22.htm IDEA: XBRL DOCUMENT
v3.21.1

Investments | 3 Months Ended
--- | ---
Mar. 31, 2021
Equity Method Investments And Joint Ventures [Abstract] |
Investments |
1 4. | Investments
Equity Method Investments The carrying value of the Company’s equity method investments was $39.6 million as of March 31, 2021 and $37.7 million as of December 31, 2020, and is included in “Investments” in the Company’s unaudited condensed consolidated statements of financial condition. The Company recognized gains of $1.5 million and $1.0 million related to its equity method investments for the three months ended March 31, 2021 and 2020, respectively. The Company’s share of the net gains or losses is reflected in “Gains (losses) on equity method investments” in the Company’s unaudited condensed consolidated statements of operations. For the three months ended March 31, 2021, the Company did not record impairment charges related to existing equity method investments. For the three months ended March 31, 2020, the Company recorded $2.5 million of impairment charges relating to existing equity method investments. The impairment was recorded in “Other income (loss)” in the Company’s unaudited condensed consolidated statements of operations. See Note 13—“Related Party Transactions,” for information regarding related party transactions with unconsolidated entities included in the Company’s unaudited condensed consolidated financial statements. Investments Carried Under Measurement Alternative The Company has acquired equity investments for which it did not have the ability to exert significant influence over operating and financial policies of the investees. These investments are accounted for using the measurement alternative in accordance with the guidance on recognition and measurement. The carrying value of these investments was $0.4 million as of both March 31, 2021 and December 31, 2020, and they are included in “Investments” in the Company’s unaudited condensed statements of financial condition. The Company did not recognize any gains, losses, or impairments relating to investments carried under the measurement alternative for both the three months ended March 31, 2021 and 2020. In addition, the Company owns membership shares, which are included in “Other assets” in the Company’s unaudited condensed consolidated statements of financial condition as of March 31, 2021 and December 31, 2020. These equity investments are accounted for using the measurement alternative in accordance with the guidance on recognition and measurement. The Company did not recognize any observable transactions for the three months ended March 31, 2021 and recognized $40 thousand of unrealized losses to reflect observable transactions for these shares during the three months ended March 31, 2020. The unrealized losses are reflected in “Other income (loss)” in the Company’s unaudited condensed consolidated statements of operations. Investments in VIEs Certain of the Company’s equity method investments are considered VIEs as defined under the accounting guidance for consolidation. The Company is not considered the primary beneficiary of and therefore does not consolidate these VIEs. The Company’s involvement with such entities is in the form of direct equity interests and related agreements. The Company’s maximum exposure to loss with respect to the VIEs is its investment in such entities, as well as a credit facility and a subordinated loan. The following table sets forth the Company’s investment in its unconsolidated VIEs and the maximum exposure to loss with respect to such entities (in thousands):
|  | March 31, 2021 |  |  | December 31, 2020 |
|  |  |  |  |  | Maximum |  |  |  |  |  |  | Maximum |
|  |  |  |  |  | Exposure to |  |  |  |  |  |  | Exposure to |
|  | Investment |  |  | Loss |  |  | Investment |  |  | Loss |
Variable interest entities1 |  | $ | 1,343 |  |  | $ | 2,323 |  |  | $ | 1,258 |  |  | $ | 2,238 |
1 | The Company has entered into a subordinated loan agreement with Aqua, whereby the Company agreed to lend the principal sum of $980 thousand. The Company’s maximum exposure to loss with respect to its unconsolidated VIEs includes the sum of its equity investments in its unconsolidated VIEs and the $980 thousand subordinated loan to Aqua.
Consolidated VIE The Company is invested in a limited liability company that is focused on developing a proprietary trading technology. The limited liability company is a VIE and it was determined that the Company is the primary beneficiary of this VIE because the Company was the provider of the majority of this VIE’s start-up capital and has the power to direct the activities of this VIE that most significantly impact its economic performance, primarily through its voting percentage and consent rights on the activities that would most significantly influence the entity. The consolidated VIE had total assets of $7.6 million and $7.2 million as of March 31, 2021 and December 31, 2020, respectively, which primarily consisted of clearing margin. There were no material restrictions on the consolidated VIE’s assets. The consolidated VIE had total liabilities of $1.4 million and $1.0 million as of March 31, 2021 and December 31, 2020, respectively. The Company’s exposure to economic loss on this VIE was $4.5 million and $4.8 million as of March 31, 2021 and December 31, 2020, respectively.

X
- Definition The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses). + References No definition available. + Details
Name: | us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration